1994 – The National Breast Cancer Foundation (NBCF) is founded and both David Jones and Estee Lauder Companies join as Corporate Partners.
1997 – Fashion Targets Breast Cancer is launched.
1997 – NBCF funds the establishment of KConFab, a national and international resource to study familial breast cancer.
1998 – Women In Super establishes the Mother’s Day Classic, now the major fundraising event for breast cancer research in Australia.
2000 – The Global Illumination campaign is launched with Estée Lauder Companies and iconic sites around Australia glow pink.
2001 – Sarah Murdoch becomes Patron.
2002 – Pink Ribbon magazine, Australia’s first ever women’s magazine focused on breast cancer, hits newsstands.
2002 – NBCF establishes itself as the leading charity in cause-related marketing.
2003 – NBCF launches its Pink Ribbon Breakfast campaign which has since raised over $20 million.
2004 – NBCF releases Australia’s first-ever National Action Plan for breast cancer research.
2005 – NBCF introduces seed funding for researchers to think outside the square with the unique Novel Concept Awards
2005 – NBCF establishes its Speakers Bureau.
2006 – NBCF funds the establishment of the first Australian Breast Cancer Tissue Bank, another national and international resource.
2006 – NBCF-funded research finds sentinel node biopsy can save women from invasive surgery.
2008 – NBCF introduces Collaborative Grants at $5 million to drive national and international research partnerships.
2010 – NBCF launches Register4, Australia’s first online resource where the community can participate in and fast-track research.
2012 – NBCF introduces Translational Grants and Practitioner Fellowships, funding to accelerate translation of research into clinical practice.
2013 – NBCF-funded research reveals that tamoxifen can reduce the risk of recurrence in high risk women.
2013 – NBCF publicly releases a world first, an independent evaluation of the impact of its program of breast cancer research, conducted by Brunel University.
2016 – 5-year survival rate reaches all-time high of 90%
2030– Zero deaths from breast cancer.